The calcium-sensing receptor in normal physiology and pathophysiology: A review

Critical Reviews in Clinical Laboratory Sciences

Volumn 42, Issue 1, 2005, Pages 35-70

  Tfelt Hansen, Jacob ^a,b   Brown, Edward M ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Acquired hypoparathyroidism; Autosomal dominant hypoparathyroidism; Calcilytic; Calcimimetic; Calcium homeostasis; Calcium sensing receptor; Familial hypocalciuric hypercalcemia; G protein; Hyperparathyroidism; Osteoporosis

Indexed keywords

1 (3 METHOXYPHENYL) N (3 PHENYLPROPYL)ETHYLAMINE; CALCIMIMETIC AGENT; CALCITONIN; CALCIUM SENSING RECEPTOR; CINACALCET; FUROSEMIDE; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N [3 (2 CHLOROPHENYL)PROPYL] 1 (3 METHOXYPHENYL)ETHYLAMINE; PAMIDRONIC ACID; PARATHYROID HORMONE; PHOSPHOLIPASE C; PROTEIN KINASE B; VITAMIN D; CALCIUM;

APOPTOSIS; AUTOIMMUNE DISEASE; BONE; CELL MEMBRANE; CELL PROLIFERATION; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG INHIBITION; EXTRACELLULAR CALCIUM; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCEMIA; HYPOPARATHYROIDISM; INTESTINE; KIDNEY; MUTATION; NONHUMAN; PARATHYROID GLAND; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STOMACH CHIEF CELL; STONE FORMATION; ANIMAL; GENETICS; HOMEOSTASIS; METABOLISM;

ANIMALS; CALCIUM; HOMEOSTASIS; HUMANS; HYPERCALCEMIA; HYPOCALCEMIA; MUTATION; RECEPTORS, CALCIUM-SENSING;

EID: 18244363907     PISSN: 10408363     EISSN: None     Source Type: Journal    
DOI: 10.1080/10408360590886606     Document Type: Review

References (212)

1. 2+-sensing receptor from bovine parathyroid. Nature 1993; 366: 575-80.
2. Herrada G, Dulac C. A novel family of putative pheromone receptors in mammals with a topographically organized and sexually dimorphic distribution. Cell 1997; 90: 763-73.
3. Matsunami H, Buck LB. A multigene family encoding a diverse array of putative pheromone receptors in mammals. Cell 1997; 90: 775-84.
4. Hoon MA, Adler E, Lindemeier J, Battey JF, Ryba NJ, Zuker CS. Putative mammalian taste receptors: A class of taste-specific GPCRs with distinct topographic selectivity. Cell 1999; 96: 541-51.
5. 2+-sensing receptor in Fugu. Proc Natl Acad Sci USA 1998; 95: 5178-81.
6. Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 2000; 16: 281-96.
7. Garrett JE, Capuano IV, Hammerland LG, et al. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995; 270: 12919-25.
8. 2+-sensing receptor cDNA from human kidney. Biochem Biophys Res Commun 1995; 214: 524-9.
9. Bai M, Trivedi S, Brown EM. Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 1998; 273: 23605-10.
10. 2+-sensing receptor: Implications for its structure and function. Trends Endocrinol Metab 2003; 14: 282-8.
11. 2+ receptor: Effects on cell surface expression, dimerization and signal transduction. FEBS Lett 1998; 436: 353-6.
12. Jensen AA, Hansen JL, Sheikh SP, Brauner-Osborne H. Probing intermolecular protein-protein interactions in the calcium-sensing receptor homodimer using bioluminescence resonance energy transfer (BRET). Eur J Biochem 2002; 269: 5076-87.
13. 2+ store release. J Biol Chem 1998; 273: 21267-75.
14. Hjalm G, MacLeod RJ, Kifor O, Chattopadhyay N, Brown EM. Filamin-A binds to the carboxyl-terminal tail of the calcium-sensing receptor, an interaction that participates in CaR-mediated activation of mitogen-activated protein kinase. J Biol Chem 2001; 276: 34880-7.
15. Kifor O, Diaz R, Butters R, Kifor I, Brown EM. The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 1998; 273: 21708-13.
16. 2+-sensing receptor (CaR) activates phospholipases C, A2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J Bone Miner Res 1997; 12: 715-25.
17. Kifor O, MacLeod RJ, Diaz R, et al. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 2001; 280: F291-302.
18. 2+-sensing receptor activates cytosolic phospholipase A2 via a Gqalpha-dependent ERK-independent pathway. J Biol Chem 2001; 276: 13941-8.
19. Huang C, Handlogten ME, Miller RT. Parallel activation of phosphatidylinositol 4-kinase and phospholipase C by the extracellular calcium-sensing receptor. J Biol Chem 2002; 277: 20293-300.
20. 2+. J Biol Chem 1998; 273: 15192-202.
21. Tfelt-Hansen J, Chattopadhyay N, Yano S, et al. Calcium-sensing receptor induces proliferation through p38 mitogen-activated protein kinase and phosphatidylinositol 3-kinase but not extracellulary regulated kinase in a model of humoral hypercalcemia of malignancy. Endocrinology 2004; 145: 1211-7. Epub 2003 Nov. 26.
22. Nemeth EF. Regulation of cytosolic calcium by extracellular divalent cations in C-cells and parathyroid cells. Cell Calcium 1990; 11: 323-7.
23. Miki H, Maercklein PB, Fitzpatrick LA. Effect of magnesium on parathyroid cells: Evidence for two sensing receptors or two intracellular pathways? Am J Physiol 1997; 272: E1-6.
24. 2+-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 1997; 200 (Pt 2): 295-302.
25. 2+-sensing receptor: A target for polyamines. Am J Physiol 1997; 273: C1315-23.
26. 2+o-sensing receptor. J Biol Chem 1996; 271: 19537-45.
27. Quinn SJ, Kifor O, Trivedi S, Diaz R, Vassilev P, Brown E. Sodium and ionic strength sensing by the calcium receptor. J Biol Chem 1998; 273: 19579-86.
28. Brown EM, MacLeod RJ. Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 2001; 81: 239-97.
29. Conigrave AD, et al. L-Amino acid sensing by the calcium-sensing receptor: A general mechanism for coupling protein and calcium metabolism? Eur J Clin Nutr 2003; 57: 879.
30. 2+-sensing receptor. Proc Natl Acad Sci USA 2000; 97: 4814-9.
31. Zhang Z, Qiu W, Quinn SJ, Conigrave AD, Brown EM, Bai M. Three adjacent serines in the extracellular domains of the CaR are required for L-amino acid-mediated potentiation of receptor function. J Biol Chem 2002; 277: 33727-35.
32. Zhang Z, Jiang Y, Quinn SJ, Krapcho K, Nemeth EF, Bai M. L-phenylalanine and NPS R-467 synergistically potentiate the function of the extracellular calcium-sensing receptor through distinct sites. J Biol Chem 2002; 277: 33736-41.
33. Tfelt-Hansen J, Schwarz P, Brown EM, Chattopadhyay N. The calcium-sensing receptor in human disease. Front Biosci 2003; 8: s377-90.
34. Tfelt-Hansen J, Schwarz P, Torring O. Rapid suppression of S-PTH by oral calcitriol and calcium in healthy premenopausal women. Scand J Clin Lab Invest 2001; 61: 395-400.
35. Schwarz P. Dose response dependency in regulation of acute PTH (1-84) release and suppression in normal humans: A citrate and calcium infusion study. Scand J Clin Lab Invest 1993; 53: 601-5.
36. Garrett JE, Tamir H, Kifor O, et al. Calcitonin-secreting cells of the thyroid express an extracellular calcium receptor gene. Endocrinology 1995; 136: 5202-11.
37. Brown AJ, Zhong M, Finch J, et al. Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 1996; 270: F454-60.
38. Murphey ED, Chattopadhyay N, Bai M, et al. Up-regulation of the parathyroid calcium-sensing receptor after burn injury in sheep: A potential contributory factor to postburn hypocalcemia. Crit Care Med 2000; 28: 3885-90.
39. 2+-sensing receptor messenger ribonucleic acid and protein. Endocrinology 1995; 136: 3087-92.
40. Brown AJ, Zhong M, Ritter C, Brown EM, Slatopolsky E. Loss of calcium responsiveness in cultured bovine parathyroid cells is associated with decreased calcium receptor expression. Biochem Biophys Res Commun 1995; 212: 861-7.
41. Corbetta S, Lania A, Filopanti M, Vicentini L, Ballare E, Spada A. Mitogen-activated protein kinase cascade in human normal and tumoral parathyroid cells. J Clin Endocrinol Metab 2002; 87: 2201-5.
42. Ward DT, Riccardi D. Renal physiology of the extracellular calcium-sensing receptor. Pflugers Arch 2002; 445: 169-76.
43. 2+-sensing receptor and PTH/PTHrP receptor in rat kidney. Am J Physiol 1996; 271: F951-6.
44. Riccardi D, Park J, Lee WS, Gamba G, Brown EM, Hebert SC. Cloning and functional expression of a rat kidney extracellular calcium/polyvalent cation-sensing receptor. Proc Natl Acad Sci USA 1995; 92: 131-5.
45. 2+/polyvalent cation-sensing protein in rat kidney. Am J Physiol 1998; 274: F611-22.
46. Canaff L, Hendy GN. Human calcium-sensing receptor gene. Vitamin D response elements in promoters P1 and P2 confer transcriptional responsiveness to 1,25-dihydroxyvitamin D. J Biol Chem 2002; 277: 30337-50.
47. Caride AJ, Chini EN, Homma S, Dousa TP, Penniston JT. mRNAs coding for the calcium-sensing receptor along the rat nephron: Effect of a low-phosphate diet. Kidney Blood Press Res 1998; 21: 305-9.
48. +-dependent Pi transporter (NaPi-2) in the rat proximal tubule. Pflugers Arch 2000; 441: 379-87.
49. Sands JM, Flores FX, Kato A, et al. Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats. Am J Physiol 1998; 274: F978-85.
50. Ba J, Brown D, Friedman PA. Calcium-sensing receptor regulation of PTH-inhibitable proximal tubule phosphate transport. Am J Physiol Renal Physiol 2003; 285: F1233-43.
51. Chattopadhyay N, Baum M, Bai M, et al. Ontogeny of the extracellular calcium-sensing receptor in rat kidney. Am J Physiol 1996; 271: F736-43.
52. Attie MF, Gill JR Jr, Stock JL, et al. Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. Clin Invest 1983; 72: 667-76.
53. Motoyama HI, Friedman PA. Calcium-sensing receptor regulation of PTH-dependent calcium absorption by mouse cortical ascending limbs. Am J Physiol Renal Physiol 2002; 283: F399-406.
54. Desfleurs E, Wittner M, Simeone S, et al. Calcium-sensing receptor: Regulation of electrolyte transport in the thick ascending limb of Henle's loop. Kidney Blood Press Res 1998; 21: 401-12.
55. Wang D, An SJ, Wang WH, McGiff JC, Ferreri NR. CaR-mediated COX-2 expression in primary cultured mTAL cells. Am J Physiol Renal Physiol 2001; 281: F658-64.
56. Wang D, McGiff JC, Ferreri NR. Regulation of cyclooxygenase isoforms in the renal thick ascending limb: Effects of extracellular calcium. J Physiol Pharmacol 2000; 51: 587-95.
57. Wang D, Pedraza PL, Abdullah HI, McGiffJC, Ferreri NR. Calcium-sensing receptor-mediated TNF production in medullary thick ascending limb cells. Am J Physiol Renal Physiol 2002; 283: F963-70.
58. 2+/polyvalent cation sensor in the mouse thick ascending limb. Am J Physiol 1996; 271: F1052-60.
59. 2+ receptor RaKCaR. J Membr Biol 1997; 156: 117-29.
60. 2+ on apical K+ channels in rat TAL. Am J Physiol 1997; 273: F421-9.
61. 2+-induced inhibition of apical K+ channels in the TAL. Am J Physiol 1996; 271: C103-11.
62. 2+ decreases chloride reabsorption in rat CTAL by inhibiting cAMP pathway. Am J Physiol 1998; 275: F198-203.
63. 2+-sensing receptor in the rabbit cortical thick ascending limb (CTAL) is functionally not coupled to phospholipase C. Pflugers Arch 1999; 437: 716-23.
64. Blankenship KA, Williams JJ, Lawrence MS, McLeish KR, Dean WL, Arthur JM. The calcium-sensing receptor regulates calcium absorption in MDCK cells by inhibition of PMGA. Am J Physiol Renal Physiol 2001; 280: F815-22.
65. Sands JM, Naruse M, Baum M, et al. Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 1997; 99: 1399-405.
66. Quarles LD, Hartle JE 2nd, Middleton JP, Zhang J, Arthur JM, Raymond JR. Aluminum-induced DNA synthesis in osteoblasts: Mediation by a G-protein coupled cation sensing mechanism. J Cell Biochem 1994; 56: 106-17.
67. Chattopadhyay N, Yano S, Tfelt-Hansen J, et al. Mitogenic action of calcium-sensing receptor on rat calvarial osteoblasts. Endocrinology 2004; 145: 3451-62.
68. Chang W, Tu C, Chen TH, et al. Expression and signal transduction of calcium-sensing receptors in cartilage and bone. Endocrinology 1999; 140: 5883-93.
69. 2+o)-sensing receptor in the clonal osteoblast-like cell lines, UMR-106 and SAOS-2. Biochem Biophys Res Commun 1998; 243: 753-7.
70. 2+o)-sensing receptor and its agonists stimulate chemotaxis and proliferation of MC3T3-E1 cells. J Bone Miner Res 1998; 13: 1530-8.
71. Yamaguchi T, Chattopadhyay N, Kifor O, Sanders JL, Brown EM. Activation of p42/44 and p38 mitogen-activated protein kinases by extracellular calcium-sensing receptor agonists induces mitogenic responses in the mouse osteoblastic MC3T3-E1 cell line. Biochem Biophys Res Commun 2000; 279: 363-8.
72. Yamaguchi T, Chattopadhyay N, Kifor O, et al. Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. Am J Physiol Cell Physiol 2001; 280: C382-93.
73. Ye CP, Yamaguchi T, Chattopadhyay N, Sanders JL, Vassilev PM, Brown EM. Extracellular calcium-sensing-receptor (CaR)-mediated opening of an outward K(+) channel in murine MC3T3-E1 osteoblastic cells: Evidence for expression of a functional CaR. Bone 2000; 27: 21-7.
74. Pi M, Hinson TK, Quarles L. Failure to detect the extracellular calcium-sensing receptor (CasR) in human osteoblast cell lines. J Bone Miner Res 1999; 14: 1310-9.
75. Kim YH, Kim JM, Kim SN, Kim GS, Baek JH. p44/42 MAPK activation is necessary for receptor activator of nuclear factor-kappaB ligand induction by high extracellular calcium. Biochem Biophys Res Commun 2003; 304: 729-35.
76. Pi M, Garner SC, Flannery P, Spurney RF, Quarles LD. Sensing of extracellular cations in CasR-deficient osteoblasts. Evidence for a novel cation-sensing mechanism. J Biol Chem 2000; 275: 3256-63.
77. 2+ sensing receptor activation in the growth plate. FASEB J 2004; 18: 143-5.
78. Kameda T, Mano H, Yamada Y, et al. Calcium-sensing receptor in mature osteoclasts, which are bone resorbing cells. Biochem Biophys Res Commun 1998; 245: 419-22.
79. Kanatani M, Sugimoto T, Kanzawa M, Yano S, Chihara K. High extracellular calcium inhibits osteoclast-like cell formation by directly acting on the calcium-sensing receptor existing in osteoclast precursor cells. Biochem Biophys Res Commun 1999; 261: 144-8.
80. 2+(o) on the function of ST2 cells. Endocrinology 1998; 139: 3561-8.
81. Lorget F, Kamel S, Mentaverri R, et al. High extracellular calcium concentrations directly stimulate osteoclast apoptosis. Biochem Biophys Res Commun 2000; 268: 899-903.
82. Shalhoub V, Grisanti M, Padagas J, et al. In vitro studies with the calcimimetic, cinacalcet HCl, on normal human adult osteoblastic and osteoclastic cells. Crit Rev Eukaryot Gene Expr 2003; 13: 89-106.
83. Tu Q, Pi M, Quarles LD. Calcyclin mediates serum response element (SRE) activation by an osteoblastic extracellular cation-sensing mechanism. J Bone Miner Res 2003; 18: 1825-33.
84. Ho C, Conner DA, Pollak MR, et al. A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 1995; 11: 389-94.
85. Garner SC, Pi M, Tu Q, Quarles LD. Rickets in cation-sensing receptor-deficient mice: An unexpected skeletal phenotype. Endocrinology 2001; 142: 3996-4005.
86. Tu Q, Pi M, Karsenty G, Simpson L, Liu S, Quarles LD. Rescue of the skeletal phenotype in CasR-deficient mice by transfer onto the Gcm2 null background. J Clin Invest 2003; 111: 1029-37.
87. Kos CH, Karaplis AC, Peng JB, et al. The calcium-sensing receptor is required for normal calcium homeostasis independent of parathyroid hormone. J Clin Invest 2003; 111: 1021-8.
88. Freichel M, Zink-Lorenz A, Holloschi A, Hafner M, Flockerzi V, Raue F. Expression of a calcium-sensing receptor in a human medullary thyroid carcinoma cell line and its contribution to calcitonin secretion. Endocrinology 1996; 137: 3842-8.
89. MacLeod RJ, Chattopadhyay N, Brown EM. PTHrP stimulated by the calcium-sensing receptor requires MAP kinase activation. Am J Physiol Endocrinol Metab 2003; 284: E435-42.
90. Tfelt-Hansen J, MacLeod RJ, Chattopadhyay N, et al. Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells. Am J Physiol Endocrinol Metab 2002; 285: E329-37.
91. Emanuel RL, Adler GK, Kifor O, et al. Calcium-sensing receptor expression and regulation by extracellular calcium in the AtT-20 pituitary cell line. Mol Endocrinol 1996; 10: 555-65.
92. Buchan AM, Squires PE, Ring M, Meloche RM. Mechanism of action of the calcium-sensing receptor in human antral gastrin cells. Gastroenterologe 2001; 120: 1128-39.
93. Squires PE, Harris TE, Persaud SJ, Curtis SB, Buchan AM, Jones PM. The extracellular calcium-sensing receptor on human beta-cells negatively modulates insulin secretion. Diabetes 2000; 49: 409-17.
94. Squires PE, Persaud SJ, Jones PM, Buchan AM. The extracellular calcium-sensing receptor in PHHI beta cells: Does reduced auto-inhibitory input contribute to hypersecretion of insulin? Diabetologia 2000; 43: 1078-80.
95. Romoli R, Lania A, Mantovani G, Corbetta S, Persani L, Spada A. Expression of calcium-sensing receptor and characterization of intracellular signaling in human pituitary adenomas. J Clin Endocrinol Metab 1999; 84: 2848-53.
96. 2+-sensing receptor agonists of nonselective cation channels in rat hippocampal neurons. Biochem Biophys Res Commun 1996; 224: 271-80.
97. Chattopadhyay N, Ye CP, Yamaguchi T, Kerner R, Vassilev PM, Brown EM. Extracellular calcium-sensing receptor induces cellular proliferation and activation of a nonselective cation channel in U373 human astrocytoma cells. Brain Res 1999; 851: 116-24.
98. 2+-activated potassium channel in glioblastoma cells transfected with a dominant negative CaR. Brain Res Mol Brain Res 2000; 80: 177-87.
99. Tfelt-Hansen J, Schwarz P, Terwilliger EF, Brown EM, Chattopadhyay N. Calcium-sensing receptor induces messenger ribonucleic acid of human securin, pituitary tumor transforming gene, in rat testicular cancer. Endocrinology 2003; 144: 5188-93.
100. Hobson SA, McNeil SE, Lee F, Rodland KD. Signal transduction mechanisms linking increased extracellular calcium to proliferation in ovarian surface epithelial cells. Exp Cell Res 2000; 258: 1-11.
101. McNeil L, Hobson S, Nipper V, Rodland KD. Functional calcium-sensing receptor expression in ovarian surface epithelial cells. Am J Obstet Gynecol 1998; 178: 305-13.
102. McNeil SE, Hobson SA, Nipper V, Rodland KD. Functional calcium-sensing receptors in rat fibroblasts are required for activation of SRC kinase and mitogen-activated protein kinase in response to extracellular calcium. J Biol Chem 1998; 273: 1114-20.
103. Bikle DD, Ng D, Tu CL, Oda Y, Xie Z. Calcium- and vitamin D-regulated keratinocyte differentiation. Mol Cell Endocrinol 2001; 177: 161-71.
104. Tu CL, Chang W, Bikle DD. The extracellular calcium-sensing receptor is required for calcium-induced differentiation in human keratinocytes. J Biol Chem 2001; 276: 41079-85.
105. Cheng I, Klingensmith ME, Chattopadhyay N, et al. Identification and localization of the extracellular calcium-sensing receptor in human breast. J Clin Endocrinol Metab 1998; 83: 703-7.
106. Lin KI, Chattopadhyay N, Bai M, et al. Elevated extracellular calcium can prevent apoptosis via the calcium-sensing receptor. Biochem Biophys Res Commun 1998; 249: 325-31.
107. 2+O on the function of J774 cells. J Bone Miner Res 1998; 13: 1390-7.
108. Hofer AM, Curci S, Doble MA, Brown EM, Soybel DI. Intercellular communication mediated by the extracellular calcium-sensing receptor. Nat Cell Biol 2000; 2: 392-8.
109. 2+] in intact polarized epithelia. EMBO J 2001; 20: 6316-26.
110. Carling T, Szabo E, Bai M, et al. Familial hypercalcemia and hypercalciuria caused by a novel mutation in the cytoplasmic tail of the calcium receptor. J Clin Endocrinol Metab 2000; 85: 2042-7.
111. [Ill] D'Souza-Li L, Canaff L, Janicic N, Cole DE, Hendy GN. An acceptor splice site mutation in the calcium-sensing receptor (CASR) gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Hum Mutat 2001; 18: 411-21.
112. 2+-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 1995; 56: 880-6.
113. Pearce SH, Trump D, Wooding C, et al. Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 1995; 96: 2683-92.
114. 2004 On-line Mendelian Inheritance in Man (OMIM). Center for Medical Genetics. John Hopkins University (Baltimore) and National Center for Biotechnology Information. National Library of Medicine (Bethesda, MD). http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM
115. Foley TP Jr, Harrison HC, Arnaud CD, Harrison HE. Familial benign hypercalcemia. J Pediatr 1972; 81: 1060-7.
116. Simonds WF, James-Newton LA, Agarwal SK, et al. Familial isolated hyperparathyroidism: Clinical and genetic characteristics of 36 kindreds. Medicine (Baltimore) 2002; 81: 1-26.
117. Warner J, Epstein M, Sweet A, et al. Genetic testing in familial isolated hyperparathyroidism: Unexpected results and their implications. J Med Genet 2004: 41: 155-60.
118. Chou YH, Brown EM, Levi T, et al. The gene responsible for familial hypocalciuric hypercalcemia maps to chromosome 3q in four unrelated families. Nat Genet 1992; 1: 295-300.
119. Heath H 3rd, Odelberg S, Jackson CE, et al. Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 1996; 81: 1312-7.
120. Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV. Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19ql3. Am J Hum Genet 1999; 64: 189-95.
121. 2+-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 1993; 75: 1297-303.
122. Bai M, Trivedi S, Kifor O, Quinn SJ, Brown EM. Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci USA 1999; 96: 2834-9.
123. 2+-sensing receptor gene in three Danish families. Scand J Clin Lab Invest 2000; 60: 221-7.
124. Pollak MR, Chou YH, Marx SJ, et al. Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 1994; 93: 1108-12.
125. Kobayashi M, Tanaka H, Tsuzuki K, et al. Two novel missense mutations in calcium-sensing receptor gene associated with neonatal severe hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 2716-9.
126. Lienhardt A, Bai M, Lagarde JP, et al. Activating mutations of the calcium-sensing receptor: Management of hypocalcemia. J Clin Endocrinol Metab 2001; 86: 5313-23.
127. Finegold DN, Armitage MM, Galiani M, et al. Preliminary localization of a gene for autosomal dominant hypoparathyroidism to chromosome 3ql3. Pediatr Res 1994; 36: 414-7.
128. 2+-sensing receptor gene mutation. Nat Genet 1994; 8: 303-7.
129. Pearce SH, Williamson C, Kifor O, et al. A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 1996; 335: 1115-22.
130. Pearce SH, Bai M, Quimi SJ, Kifor O, Brown EM, Thakker RV. Functional characterization of calcium-sensing receptor mutations expressed in human embryonic kidney cells. J Clin Invest 1996; 98: 1860-6.
131. D'Souza-Li L, Yang B, Canaff L, et al. Identification and functional characterization of novel calcium-sensing receptor mutations in familial hypocalciuric hypercalcemia and autosomal dominant hypocalcemia. J Clin Endocrinol Metab 2002; 87: 1309-18.
132. Hirai H, Nakajima S, Miyauchi A, et al. A novel activating mutation (C129S) in the calcium-sensing receptor gene in a Japanese family with autosomal dominant hypocalcemia. J Hum Genet 2001; 46: 41-4.
133. 2+-sensing receptor gene: Normal maternal calcium homeostasis as a cause of secondary hyperparathyroidism in familial benign hypocalciuric hypercalcemia. J Clin Invest 1997; 99: 88-96.
134. Marx SJ, Attie MF, Spiegel AM, Levine MA, Lasker RD, Fox M. An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med 1982; 306: 257-64.
135. Heath H 3rd. Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am 1989; 18: 723-40.
136. Auwerx J, Demedts M, Bouillon R. Altered parathyroid set point to calcium in familial hypocalciuric hypercalcaemia. Acta Endocrinol (Copenh) 1984; 106: 215-8.
137. Khosla S, Ebeling PR, Firek AF, Burritt MM, Kao PC, Heath H 3rd. Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism. J Clin Endocrinol Metab 1993; 76: 715-20.
138. Brown EM. Physiology and pathophysiology of the extracellular calcium-sensing receptor. Am J Med 1999; 106: 238-53.
139. Marx SJ, Attie MF, Stock JL, Spiegel AM, Levine MA. Maximal urine-concentrating ability: Familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 1981; 52: 736-40.
140. Burski K, Torjussen B, Paulsen AQ, Boman H, Bollerslev J. Parathyroid adenoma in a subject with familial hypocalciuric hypercalcemia: Coincidence or causality? J Clin Endocrinol Metab 2002; 87: 1015-6.
141. Fukumoto S, Chikatsu N, Okazaki R, et al. Inactivating mutations of calcium-sensing receptor results in parathyroid lipohyperplasia. Diagn Mol Pathol 2001; 10: 242-7.
142. Yamauchi M, Sugimoto T, Yamaguchi T, et al. Familial hypocalciuric hypercalcemia caused by an R648stop mutation in the calcium-sensing receptor gene. J Bone Miner Res 2002; 17: 2174-82.
143. Cole DE, Janicic N, Salisbury SR, Hendy GN. Neonatal severe hyperparathyroidism, secondary hyperparathyroidism, and familial hypocalciuric hypercalcemia: Multiple different phenotypes associated with an inactivating Alu insertion mutation of the calcium-sensing receptor gene. Am J Med Genet 1997; 71: 202-10.
144. Grantmyre EB. Roentgenographic features of "primary" hyperparathyroidism in infancy. J Can Assoc Radiol 1973; 24: 257-60.
145. Eftekhari F, Yousefzadeh DK. Primary infantile hyperparathyroidism: Clinical, laboratory, and radiographic features in 21 cases. Skeletal Radiol 1982; 8: 201-8.
146. 2+-sensing receptor gene. J Clin Endocrinol Metab 1995; 80: 2594-8.
147. Yamamoto M, Akatsu T, Nagase T, Ogata E. Comparison of hypocalcemic hypercalciuria between patients with idiopathic hypoparathyroidism and those with gain-of-function mutations in the calcium-sensing receptor: Is it possible to differentiate the two disorders? J Clin Endocrinol Metab 2000; 85: 4583-91.
148. Okazaki R, Chikatsu N, Nakatsu M, et al. A novel activating mutation in calcium-sensing receptor gene associated with a family of autosomal dominant hypocalcemia. J Clin Endocrinol Metab 1999; 84: 363-6.
149. Vargas-Poussou R, Huang C, Hulin P, et al. Functional characterization of a calcium-sensing receptor mutation in severe autosomal dominant hypocalcemia with a Bartter-like syndrome. J Am Soc Nephrol 2002; 13: 2259-66.
150. Watanabe S, Fukumoto S, Chang H, et al. Association between activating mutations of calcium-sensing receptor and Bartter's syndrome. Lancet 2002; 360: 692-4.
151. Blizzard RM, Chee D, Davis W. The incidence of adrenal and other antibodies in the sera of patients with idiopathic adrenal insufficiency (Addison's disease). Clin Exp Immunol 1967; 2: 19-30.
152. Posillico JT, Wortsman J, Srikanta S, Eisenbarth GS, Mallette LE, Brown EM. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res 1986; 1: 475-83.
153. Li Y, Song YH, Rais N, et al. Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 1996; 97: 910-4.
154. Kifor O, McElduff A, LeBoff MS, et al. Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism. J Clin Endocrinol Metab 2004; 89: 548-56.
155. Goswami R, Brown EM, Kochupillai N, et al. Prevalence of calcium sensing receptor autoantibodies in patients with sporadic idiopathic hypoparathyroidism. Eur J Endocrinol 2004; 150: 9-18.
156. Soderbergh A, Myhre AG, Ekwall O, et al. Prevalence and clinical associations of 10 defined autoantibodies in autoimmune polyendocrine syndrome type I. J Clin Endocrinol Metab 2004; 89: 557-62.
157. Kifor O, Moore FD Jr, Delaney M, et al. A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor. J Clin Endocrinol Metab 2003; 88: 60-72.
158. 2+-sensing receptor gene in human parathyroid tumors. J Clin Endocrinol Metab 1995; 80: 3107-10.
159. Martin-Salvago M, Villar-Rodriguez JL, Palma-Alvarez A, Beato-Moreno A, Galera-Davidson H. Decreased expression of calcium receptor in parathyroid tissue in patients with hyperparathyroidism secondary to chronic renal failure. Endocr Pathol 2003; 14: 61-70.
160. Yano S, Sugimoto T, Tsukamoto T, et al. Decrease in vitamin D receptor and calcium-sensing receptor in highly proliferative parathyroid adenomas. Eur J Endocrinol 2003; 148: 403-11.
161. Valimaki S, Farnebo F, Forsberg L, Larsson C, Farnebo LO. Heterogeneous expression of receptor mRNAs in parathyroid glands of secondary hyperparathyroidism. Kidney Int 2001; 60: 1666-75.
162. Gogusev J, Duchambon P, Hory B, et al. Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 1997; 51: 328-36.
163. Farnebo F, Enberg U, Grimelius L, et al. Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 1997; 82: 3481-6.
164. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 1598-606.
165. 2+-sensing receptor expression in parathyroid adenoma. Calcif Tissue Int 1999; 64: 271-2.
166. Garner SC, Hinson TK, McCarty KS, Leight M, Leight GSJr, Quarles LD. Quantitative analysis of the calcium-sensing receptor messenger RNA in parathyroid adenomas. Surgery 1997; 122: 1166-75.
167. Brown AJ, Ritter CS, Finch JL, Slatopolsky EA. Decreased calcium-sensing receptor expression in hyperplastic parathyroid glands of uremic rats: Role of dietary phosphate. Kidney Int 1999; 55: 1284-92.
168. Yano S, Sugimoto T, Tsukamoto T, et al. Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 2000; 58: 1980-6.
169. Ritter CS, Finch JL, Slatopolsky KA, Brown AJ. Parathyroid hyperplasia in uremic rats precedes down-regulation of the calcium receptor. Kidney Int 2001; 60: 1737-44.
170. Ritter CS, Martin DR, Lu Y, Slatopolsky E, Brown AJ. Reversal of secondary hyperparathyroidism by phosphate restriction restores parathyroid calcium-sensing receptor expression and function. J Bone Miner Res 2002; 17: 2206-13.
171. Lewin E, Garfia B, Recio FL, Rodriguez M, Olgaard K. Persistent downregulation of calcium-sensing receptor mRNA in rat parathyroids when severe secondary hyperparathyroidism is reversed by an isogenic kidney transplantation. J Am Soc Nephrol 2002; 13: 2110-6.
172. Cole DE, Peltekova VD, Rubin LA, et al. A986S polymorphism of the calcium-sensing receptor and circulating calcium concentrations. Lancet 1999; 353: 112-5.
173. Cole DE, Vieth R, Trang HM, Wong BY, Hnidy GN, Rubin KA. Association between total serum calcium and the A986S polymorphism of the calcium-sensing receptor gene. Mol Genet Metab 2001; 72: 168-74.
174. Yano S, Sugimoto T, Kanzawa M, et al. Association of polymorphic alleles of the calcium-sensing receptor gene with parathyroid hormone secretion in hemodialysis patients. Nephron 2000; 85: 317-23.
175. Lorentzon M, Lorentzon R, Lerner UH, Nordstrom P. Calcium sensing receptor gene polymorphism, circulating calcium concentrations and bone mineral density in healthy adolescent girls. Eur J Endocrinol 2001; 144: 257-61.
176. Cetani F, Borsari S, Vignali E, et al. Calcium-sensing receptor gene polymorphisms in primary hyperparathyroidism. J Endocrinol Invest 2002; 25: 614-9.
177. Cetani F, Pardi E, Borsari S, et al. Calcium-sensing receptor gene polymorphism is not associated with bone mineral density in Italian postmenopausal women. Eur J Endocrinol 2003; 148: 603-7.
178. Tsukamoto K, Orimo H, Hosoi T, et al. Association of bone mineral density with polymorphism of the human calcium-sensing receptor locus. Calcif Tissue Int 2000; 66: 181-3.
179. Yamauchi M, Sugimoto T, Yamaguchi T, et al. Association of polymorphic alleles of the calcium-sensing receptor gene with the clinical severity of primary hyperparathyroidism. Clin Endocrinol (Oxf) 2001; 55: 373-9.
180. Yokoyama K, Shigematsu T, Tsukada T, et al. Calcium-sensing receptor gene polymorphism affects the parathyroid response to moderate hypercalcemic suppression in patients with end-stage renal disease. Clin Nephrol 2002; 57: 131-5.
181. Hoff AO, Cote GJ, Fritsche HA Jr, Qiu H, Schultz PN, Gagel RF. Calcium-induced activation of a mutant G-protein-coupled receptor causes in vitro transformation of NIH/3T3 cells. Neoplasia 1999; 1: 485-91.
182. Kallay E, Bajna E, Wrba F, Kriwanek S, Peterlik M, Cross HS. Dietary calcium and growth modulation of human colon cancer cells: Role of the extracellular calcium-sensing receptor. Cancer Detect Prev 2000; 24: 127-36.
183. Kallay E, Kifor O, Chattopadhyay N, et al. Calcium-dependent c-myc proto-oncogene expression and proliferation of Caco-2 cells: A role for a luminal extracellular calcium-sensing receptor. Biochem Biophys Res Commun 1997; 232: 80-3.
184. Sheinin Y, Kallay E, Wrba F, Kriwanek S, Peterlik M, Cross HS. Immunocytochemical localization of the extracellular calcium-sensing receptor in normal and malignant human large intestinal mucosa. J Histochem Cytochem 2000; 48: 595-602.
185. Kallay E, Bonner E, Wrba F, Thakker RV, Peterlik M, Cross HS. Molecular and functional characterization of the extracellular calcium-sensing receptor in human colon cancer cells. Oncol Res 2003; 13: 551-9.
186. Chakrabarty S, Radjendirane V, Appelman H, Varani J. Extracellular calcium and calcium sensing receptor function in human colon carcinomas: Promotion of E-cadherin expression and suppression of beta-catenin/TCF activation. Cancer Res 2003; 63: 67-71.
187. Goebel SU, Peghini PL, Goldsmith PK, et al. Expression of the calcium-sensing receptor in gastrinomas. J Clin Endocrinol Metab 2000; 85: 4131-7.
188. Itami A, Kato M, Komoto I, et al. Human gastrinoma cells express calcium-sensing receptor. Life Sci 2001; 70: 119-29.
189. Buchs N, Manen D, Bonjour JP, Rizzoli R. Calcium stimulates parathyroid hormone-related protein production in Leydig tumor cells through a putative cation-sensing mechanism. Eur J Endocrinol 2000; 142: 500-5.
190. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Brown EM. Extracellular calcium-sensing receptor (CaR) expression and its potential role in parathyroid hormone-related peptide (PTHrP) secretion in the H-500 rat Leydig cell model of humoral hypercalcemia of malignancy. Biochem Biophys Res Commun 2000; 269: 427-32.
191. 2+-sensing receptor expression and PTHrP secretion in PC-3 human prostate cancer cells. Am J Physiol Endocrinol Metab 2001; 281: E1267-74.
192. 2+-sensing receptor in human astrocytes, astrocytomas, and meningiomas. Am J Physiol Cell Physiol 2000; 279: C691-9.
193. Sanders JL, Chattopadhyay N, Kifor O, Yamaguchi T, Butters RR, Brown EM. Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. Endocrinology 2000; 141: 4357-64.
194. Nemeth EF, Steffey ME, Hammerland LG, et al. Calcimimetics with potent and selective activity on the parathyroid calcium receptor. Proc Natl acad Sci USA 1998; 95: 4040-5.
195. Mailland M, Waelchli R, Ruat M, Boddeke HG, Seuwen K. Stimulation of cell proliferation by calcium and a calcimimetic compound. Endocrinology 1997; 138: 3601-5.
196. Silverberg SJ, Bone HG 3rd, Marriott TB, et al. Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 1997; 337: 1506-10.
197. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ. Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 1998; 83: 1083-8.
198. Shoback DM, Bilezikian JP, Turner SA, McCary LC, Guo MD, Peacock M. The calcimimetic cinacalcet normalizes serum calcium in subjects with primary hyperparathyroidism. J Clin Endocrinol Metab 2003; 88: 5644-9.
199. Ogata H, Ritz E, Odoni G, Amann K, Orth SR. Beneficial effects of calcimimetics on progression of renal failure and cardiovascular risk factors. J Am Soc Nephrol 2003; 14: 959-67.
200. Roussanne MC, Lieberherr M, Souberbielle JC, Sarfati E, Drucke T, Bourdeau A. Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate. Eur J Clin Invest 2001; 31: 610-6.
201. Wada M, Ishii H, Furuya Y, Fox J, Nemeth EF, Nagano N. NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int 1998; 53: 448-53.
202. Wada M, Nagano N, Furuya Y, Chin J, Nemeth EF, Fox J. Calcimimetic NPS R-568 prevents parathyroid hyperplasia in rats with severe secondary hyperparathyroidism. Kidney Int 2000; 57: 50-8.
203. Wada M, Furuya Y, Sakiyama J, et al. The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor. J Clin Invest l997; 100: 2977-83.
204. Fox J, Lowe SH, Conklhi RL, Nemeth EF. The calcimimetic NPS R-568 decreases plasma PTH in rats with mild and severe renal or dietary secondary hyperparathyroidism. Endocrine 1999; 10: 97-103.
205. Chin J, Miller SC, Wada M, Nagano N, Nemeth EF, Fox J. Activation of the calcium receptor by a calcimimetic compound halts the progression of secondary hyperparathyroidism in uremic rats. J Am Soc Nephrol 2000; 11: 903-11.
206. Antonsen JE, Sherrard DJ, Andress DL. A calcimimetic agent acutely suppresses parathyroid hormone levels in patients with chronic renal failure. Rapid communication. Kidney Int 1998; 53: 223-7.
207. Goodman WG, Frazao JM, Goodkin DA, Turner SA, Liu W, Coburn JW. A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism. Kidney Int 2000; 58: 436-45.
208. Goodman WG, Hladik GA, Turner SA, et al. The calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism. J Am Soc Nephrol 2002; 13: 1017-24.
209. Lindberg JS, Moe SM, Goodman WG, et al. The calcimimetic AMG 073 reduces parathyroid hormone and calcium × phosphorus in secondary hyperparathyroidism. Kidney Int 2003; 63: 248-54.
210. 2+-sensing in guard cells. Nature 2003; 425: 196-200.
211. 2+]i signaling expressed by GCT23 osteoclast-like cells. Proc Assoc Am Physicians 1999; 111: 70-81.
212. Gowen M, Stroup GB, Dodds RA, et al. Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic rats. J Clin Invest 2000; 105: 1595-604.